Dr. Abraham Chachoua is the Director of the Lung Cancer Center at the Perlmutter Cancer Center of NYU Langone. In his role, he specializes in treating thoracic cancers including lung cancer and malignant pleural mesothelioma. A recognized leader in lung cancer therapy, Dr. Chachoua became interested in the field of medicine, particularly in oncology, after
Dr. Andrea Wolf is a thoracic surgeon and Director of the New York Mesothelioma Program at the Mount Sinai Health System. She offers patients diagnosed with malignant pleural mesothelioma expertise in the treatment of her disease and skill in the use of a video-assisted thoracoscopic surgical procedure known as lobectomy. She is also skilled in
Dr. Kenneth Rosenzweig is a radiation oncologist at Mount Sinai Medical Center and a Professor and Chairman of the Department of Radiation Oncology at the Mount Sinai Icahn School of Medicine. He specializes in treating patients with malignant pleural mesothelioma, lung cancer, and other thoracic malignancies. His work in introducing new technology into radiation therapy
Dr. Charles A. Powell is the Chief of the Division of Pulmonary, Critical Care, and Sleep Medicine at the Icahn School of Medicine at Mount Sinai and an integral part of the facility’s lung cancer team. His clinical and research interests in malignant pleural mesothelioma make significant contributions to the multidisciplinary team’s approach to individual
Dr. Benjamin Herzberg is a medical oncologist practicing in New York City at the Herbert Irving Comprehensive Cancer Center. He specializes in treating thoracic malignancies, including malignant pleural mesothelioma, non-small cell lung cancer, small cell lung cancer, and thymoma. Dr. Herzberg is committed to providing compassionate, individualized care for his patients. His empathy is driven
Dr. Sai Yendamuri treats patients with lung cancer, malignant pleural mesothelioma, and other thoracic malignancies using minimally invasive surgery. Dr. Yendamuri says that the complexity of malignant mesothelioma requires a multidisciplinary approach to treatment that includes coordination of chemotherapy, radiation therapy, and surgery that considers the needs of the individual patient. Dr. Yendamuri’s clinical expertise includes
Dr. Brendon M. Stiles is a thoracic surgeon who specializes in treating lung and esophageal cancers and unusual and rare thoracic cancers, including malignant pleural mesothelioma. He is the Chief of Thoracic Surgery and Surgical Oncology at Montefiore Einstein Comprehensive Cancer Center, as well as a Professor of Cardiothoracic Surgery and Associate Director of Surgical
Dr. Balazs Halmos is the Director of Thoracic Oncology, Director of Clinical Cancer Genomics, and Associate Director of Clinical Science at Montefiore Einstein Comprehensive Cancer Center. As one of three team leaders of the center’s lung cancer team, his clinical focus is on the management of patients with thoracic malignancies, including malignant pleural mesothelioma and
Dr. Benjamin Medina is a thoracic surgeon at the Rutgers Cancer Institute of New Jersey and RWJBarnabas Health. He specializes in thoracic malignancies including lung cancer and malignant pleural mesothelioma, as well as esophageal cancer, mediastinal tumors, and chest wall tumors, using robotic and minimally invasive techniques that minimize pain, shorten hospital stays, and provide
While malignant mesothelioma remains a fatal diagnosis, innovations in surgical techniques and other treatments have made a significant impact on overall survival and quality of life. A recent study conducted by researchers from Kaiser Permanente in Northern California confirmed that increased specialization of mesothelioma physicians and the use of bi-disciplinary tumor boards makes a significant